Shaffer D, Hammer S M, Monaco A P
Am J Surg. 1987 Apr;153(4):381-6. doi: 10.1016/0002-9610(87)90582-4.
Infectious complications within 1 year of cadaveric kidney transplantation were compared in 45 patients treated with azathioprine, prednisone, and antilymphocyte globulin and 38 patients treated with cyclosporine and prednisone. Although there was no difference in the 1 year patient or graft survival rate, cyclosporine-treated patients had significantly fewer wound infections, infection-related transplant nephrectomies, and infection-related graft failures than azathioprine-treated patients. The cyclosporine-treated diabetic recipients had more nonviral pneumonias and opportunistic infections but fewer cases of infection-related transplant nephrectomy than did the azathioprine-treated diabetic patients. Our data suggest cyclosporine is associated with reduced infectious morbidity after cadaveric kidney transplantation in nondiabetic patients.
对45例接受硫唑嘌呤、泼尼松和抗淋巴细胞球蛋白治疗的患者以及38例接受环孢素和泼尼松治疗的患者,比较了尸体肾移植术后1年内的感染并发症情况。虽然患者和移植物的1年生存率无差异,但与硫唑嘌呤治疗的患者相比,接受环孢素治疗的患者伤口感染、感染相关的移植肾切除术以及感染相关的移植物失功率显著更少。接受环孢素治疗的糖尿病受者非病毒性肺炎和机会性感染更多,但感染相关的移植肾切除术病例比接受硫唑嘌呤治疗的糖尿病患者更少。我们的数据表明,环孢素与非糖尿病患者尸体肾移植术后感染发病率降低相关。